SPAG5 as a prognostic biomarker and chemotherapy sensitivity predictor in breast cancer: a retrospective, integrated genomic, transcriptomic, and protein analysis-Reference-Cited by-同舟云学术

SPAG5 as a prognostic biomarker and chemotherapy sensitivity predictor in breast cancer: a retrospective, integrated genomic, transcriptomic, and protein analysis

Published:2016-07 Issue:7 Volume:17 Page:1004-1018
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Abdel-Fatah Tarek M A,Agarwal Devika,Liu Dong-Xu,Russell Roslin,Rueda Oscar M,Liu Karen,Xu Bing,Moseley Paul M,Green Andrew R,Pockley Alan G,Rees Robert C,Caldas Carlos,Ellis Ian O,Ball Graham R,Chan Stephen Y T

Publisher

Elsevier BV

Subject

Oncology

Reference36 articles.

1. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012;Ferlay;Eur J Cancer,2013

2. Long-term outcome prediction by clinicopathological risk classification algorithms in node-negative breast cancer—comparison between Adjuvant!, St Gallen, and a novel risk algorithm used in the prospective randomized Node-Negative-Breast Cancer-3 (NNBC-3) trial

3. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials;Peto;Lancet,2012

4. Personalized medicine: marking a new epoch in cancer patient management;Diamandis;Mol Cancer Res,2010

5. K n breast cancer: prognostic and predictive potential;Yerushalmi;Lancet Oncol,2010

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting of mutant-p53 and MYC as a novel strategy to inhibit oncogenic SPAG5 activity in triple negative breast cancer;Cell Death & Disease;2024-08-20

2. GSDME-mediated pyroptosis promotes anti-tumor immunity of neoadjuvant chemotherapy in breast cancer;Cancer Immunology, Immunotherapy;2024-07-02

3. Sperm-Associated Antigen 5 Knockout Reduces Doxorubicin and Docetaxel Resistance in Triple-Negative Breast Cancer MDA-MB-231 and BT549 Cells;Cancers;2024-03-24

4. The ‘analysis of gene expression and biomarkers for point-of-care decision support in Sepsis‘ study; temporal clinical parameter analysis and validation of early diagnostic biomarker signatures for severe inflammation andsepsis-SIRS discrimination;Frontiers in Immunology;2024-01-25

5. KNSTRN Is a Prognostic Biomarker That Is Correlated with Immune Infiltration in Breast Cancer and Promotes Cell Cycle and Proliferation;Biochemical Genetics;2024-01-10